HC Advisors, LLC - Q1 2021 holdings

$155 Million is the total value of HC Advisors, LLC's 89 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 40.6% .

 Value Shares↓ Weighting
SCHE SellSCHWAB STRATEGIC TRemrg mkteq etf$7,134,000
+2.6%
224,483
-1.0%
4.61%
-3.0%
IEF SelliShares Treasury 7-10 Yr Bondbarclays 7 10 yr$6,247,000
-8.1%
55,321
-2.4%
4.04%
-13.1%
IYW SelliShares US Tech ETFu.s. tech etf$6,126,000
-0.8%
69,853
-3.7%
3.96%
-6.2%
IYF SelliShares US Financials ETFu.s. finls etf$5,434,000
+6.0%
72,584
-5.5%
3.51%
+0.2%
SCHP SellSCHWAB STRATEGIC TRus tips etf$5,412,000
-3.4%
88,490
-2.0%
3.50%
-8.7%
IYH SelliShares US Healthcare ETFus hlthcare etf$3,148,000
+0.5%
12,470
-2.1%
2.04%
-5.0%
NRGX SellPIMCO ENRGY TACTICAL CR OPP$781,000
+15.2%
75,413
-10.1%
0.50%
+9.1%
ALXO SellALX ONCOLOGY HLDGS INC$660,000
-21.9%
8,945
-8.8%
0.43%
-26.1%
INTC SellIntel Corp$380,000
+25.0%
5,940
-2.7%
0.25%
+18.3%
KL SellKIRKLAND LAKE GOLD LTD$354,000
-26.7%
10,465
-10.6%
0.23%
-30.6%
AEM SellAGNICO EAGLE MINES F$319,000
-28.5%
5,519
-12.7%
0.21%
-32.5%
CSCO SellCISCO SYS INC$290,000
-5.5%
5,606
-18.2%
0.19%
-11.0%
DIS SellDISNEY WALT CO$257,000
+1.6%
1,393
-0.3%
0.17%
-4.0%
APLS SellAPELLIS PHARMACEUTICALS INC$237,000
-27.5%
5,523
-3.4%
0.15%
-31.7%
GOOGL SellALPHABET INCcap stk cl a$237,000
-43.7%
115
-52.1%
0.15%
-46.9%
CYTK SellCYTOKINETICS INC$210,000
-66.0%
9,009
-69.7%
0.14%
-67.8%
BDTX SellBLACK DIAMOND THERAPEUTICS I$202,000
-25.5%
8,330
-1.6%
0.13%
-29.2%
AWP SellABERDEEN GLOBAL PREMIER PPTY$190,000
+10.5%
31,871
-2.6%
0.12%
+4.2%
EQX SellEQUINOX GOLD CORP$136,000
-30.3%
17,011
-9.8%
0.09%
-33.8%
AKBA ExitAKEBIA THERAPEUTICS INC$0-14,000
-100.0%
-0.03%
HDGE ExitRANGER EQUITY BEadvisorshares tr$0-25,000
-100.0%
-0.05%
SILV ExitSILVERCREST METALS INC$0-11,695
-100.0%
-0.09%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-14,791
-100.0%
-0.18%
GNOG ExitGOLDEN NUGGET ONLINE GAMIN$0-13,136
-100.0%
-0.18%
ETNB Exit89BIO INC$0-10,826
-100.0%
-0.18%
FIS ExitFIDELITY NATL INFORMATION SV$0-2,000
-100.0%
-0.19%
MTCH ExitMATCH GROUP INC NEW$0-2,158
-100.0%
-0.22%
BNTX ExitBIONTECH SEsponsored ads$0-4,072
-100.0%
-0.23%
UMRX ExitUNUM THERAPEUTICS INC$0-31,395
-100.0%
-0.24%
TGTX ExitTG THERAPEUTICS INC$0-12,834
-100.0%
-0.46%
SRPT ExitSAREPTA THERAPEUTICS INC$0-4,282
-100.0%
-0.50%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-7,450
-100.0%
-0.63%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC16Q3 202310.5%
MICROSOFT CORP16Q3 20237.2%
Vanguard Total Stock Mkt15Q3 202319.5%
SCHWAB STRATEGIC TR15Q3 202317.7%
Schwab US TIPS ETF15Q3 20237.1%
iShares Treasury 7-10 Yr Bond15Q3 202313.9%
SCHWAB STRATEGIC TR15Q3 20235.9%
iShares US Tech ETF15Q3 20234.6%
iShares US Financials ETF15Q3 20235.0%
SCHWAB STRATEGIC TR15Q3 20233.7%

View HC Advisors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-01-25
13F-HR2023-11-07
13F-HR2023-08-10
13F-HR2023-05-08
13F-HR2023-02-09
13F-HR2022-11-10
13F-HR2022-08-08
13F-HR2022-05-06
13F-HR2022-02-02

View HC Advisors, LLC's complete filings history.

Compare quarters

Export HC Advisors, LLC's holdings